These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29086678)

  • 1. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
    Meng LY; Wang B; Ma MG; Zhu JF
    Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
    Elzoghby AO
    Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced nanocarriers based on heparin and its derivatives for cancer management.
    Yang X; Du H; Liu J; Zhai G
    Biomacromolecules; 2015 Feb; 16(2):423-36. PubMed ID: 25517794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
    Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
    Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zein-based Nanocarriers as Potential Natural Alternatives for Drug and Gene Delivery: Focus on Cancer Therapy.
    Elzoghby A; Freag M; Mamdouh H; Elkhodairy K
    Curr Pharm Des; 2017; 23(35):5261-5271. PubMed ID: 28641543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, Quality Control and Safety Issues of Nanocarriers Used for Cancer Treatment.
    Bianco ID; Ceballos MR; Casado C; Dabbene VG; Rizzi C; Mizutamari RK
    Curr Pharm Des; 2017; 23(35):5413-5425. PubMed ID: 28911309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.
    Viale M; Tosto R; Giglio V; Pappalardo G; Oliveri V; Maric I; Mariggiò MA; Vecchio G
    Invest New Drugs; 2019 Aug; 37(4):771-778. PubMed ID: 30556100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
    Pathak K; Akhtar N
    Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.